Literature DB >> 7687434

Identification of a plasma membrane protein that specifically binds bleomycin.

G Pron1, J Belehradek, L M Mir.   

Abstract

In this paper, the association of radiolabelled bleomycin on the plasma membrane of DC-3F cells is shown to be saturable, displaying classical features of a ligand-receptor binding. This association corresponds to the presence of 140,000 to 400,000 binding sites at the surface of the cells with a half-saturating concentration of 5 microM. Moreover, using a gel electrophoresis procedure to separate membrane proteins incubated with radiolabelled bleomycin, we demonstrate the existence of a membrane protein of about 250kDa able to specifically bind bleomycin. This membrane bleomycin-binding protein could play a major part in the association of bleomycin with the cells and in its further internalization, a process that has not been elucidated yet.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7687434     DOI: 10.1006/bbrc.1993.1824

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Comparative roles of the cell wall and cell membrane in limiting uptake of xenobiotic molecules by Saccharomyces cerevisiae.

Authors:  Mustapha Aouida; Omar Tounekti; Omrane Belhadj; Lluis M Mir
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

Review 2.  Electrochemotherapy for treatment of skin and soft tissue tumours. Update and definition of its role in multimodal therapy.

Authors:  Vicente Muñoz Madero; Gloria Ortega Pérez
Journal:  Clin Transl Oncol       Date:  2011-01       Impact factor: 3.405

3.  Conserved molecular mechanisms underlying the effects of small molecule xenobiotic chemotherapeutics on cells.

Authors:  Hemant Sarin
Journal:  Mol Clin Oncol       Date:  2015-12-16

4.  The effects of low irradiance long duration photochemical internalization on glioma spheroids.

Authors:  Diane Shin; Lina Nguyen; Mai T Le; David Ju; Jimmy N Le; Kristian Berg; Henry Hirschberg
Journal:  Photodiagnosis Photodyn Ther       Date:  2019-05-07       Impact factor: 3.631

Review 5.  Electrochemotherapy in head and neck cancer: A review of an emerging cancer treatment.

Authors:  Armando De Virgilio; Massimo Ralli; Lucia Longo; Patrizia Mancini; Giuseppe Attanasio; Francesca Atturo; Marco De Vincentiis; Antonio Greco
Journal:  Oncol Lett       Date:  2018-07-12       Impact factor: 2.967

6.  Characterization of a transport and detoxification pathway for the antitumour drug bleomycin in Saccharomyces cerevisiae.

Authors:  Mustapha Aouida; Anick Leduc; Huijie Wang; Dindial Ramotar
Journal:  Biochem J       Date:  2004-11-15       Impact factor: 3.857

7.  Isolation and characterization of Saccharomyces cerevisiae mutants with enhanced resistance to the anticancer drug bleomycin.

Authors:  Mustapha Aouida; Omar Tounekti; Anick Leduc; Omrane Belhadj; Lluis Mir; Dindial Ramotar
Journal:  Curr Genet       Date:  2004-03-09       Impact factor: 3.886

Review 8.  Protective mechanisms against the antitumor agent bleomycin: lessons from Saccharomyces cerevisiae.

Authors:  Dindial Ramotar; Huijie Wang
Journal:  Curr Genet       Date:  2003-04-16       Impact factor: 3.886

9.  Genetic ablation of caveolin-2 sensitizes mice to bleomycin-induced injury.

Authors:  Cecilia J G de Almeida; Jean-François Jasmin; Francesco Del Galdo; Michael P Lisanti
Journal:  Cell Cycle       Date:  2013-07-15       Impact factor: 4.534

Review 10.  Adjuvant electrochemotherapy in veterinary patients: a model for the planning of future therapies in humans.

Authors:  Enrico P Spugnini; Gennaro Citro; Alfonso Baldi
Journal:  J Exp Clin Cancer Res       Date:  2009-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.